Malignant glomus tumors.

Laryngoscope

Department of Otolaryngology-Head and Neck Surgery, Baylor University, Houston, Texas, USA.

Published: January 1999

Objectives/hypothesis: To ascertain the incidence of malignancy in a large glomus and skull base series and to compare the clinical course of such patients with those who do not have malignant skull base lesions.

Study Design: Retrospective review of all skull base surgery cases treated at the Otology Group between 1970 and 1995.

Results: In a series of 175 jugulotympanic glomus tumors, 9 cases (5.1%) were identified. The surgery required for their extirpation is more extensive than nonmalignant glomus tumors. Attendant deficits and mortality from these procedures are accordingly greater. Five-year survival in this limited population was 72%. Prolonged periods of survival are possible with distant metastases.

Conclusions: This rate of malignancy should advocate against a watchful, waiting approach. Radiation therapy is not advocated as a primary modality for this type of tumor, as it may lead to recurrence/persistence with either subsequent malignant degeneration and metastases or local recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00005537-199901000-00007DOI Listing

Publication Analysis

Top Keywords

glomus tumors
12
skull base
12
malignant glomus
4
tumors objectives/hypothesis
4
objectives/hypothesis ascertain
4
ascertain incidence
4
incidence malignancy
4
malignancy large
4
large glomus
4
glomus skull
4

Similar Publications

Juxtaglomerular cell tumor (JxGCT) is a rare type of renal neoplasm demonstrating morphologic overlap with some mesenchymal tumors such as glomus tumor (GT) and solitary fibrous tumor (SFT). Its oncogenic drivers remain elusive, and only a few cases have been analyzed with modern molecular techniques. In prior studies, loss of chromosomes 9 and 11 appeared to be recurrent.

View Article and Find Full Text PDF

Introduction: The ZAP-X® Gyroscopic Radiosurgery System (ZAP Surgical Systems, Inc., San Carlos, CA, USA) is expected to be a highly accurate next-generation treatment system that enables gyro-stereotactic irradiation of intracranial lesions. In this study, we report the initial treatment course using ZAP-X for intracranial lesions that recurred after Gamma Knife (GK) treatment.

View Article and Find Full Text PDF

A case report: Multiple synchronous pain full glomus tumors in adjacent fingers; a review of multiple glomus tumors.

Int J Surg Case Rep

December 2024

Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address:

Introduction: Glomus tumors (GTs) are uncommon tumors that often appear as a single lesion in the subungual region. Multiple GT is a rare clinical entity that can be associated with other diseases or in the context of genetic mutations. However, the occurrence of solitary GTs simultaneously has also been reported rarely.

View Article and Find Full Text PDF
Article Synopsis
  • * Imaging tests revealed a significant mass in the left bladder and a nonfunctional right kidney, leading to surgical removal of both the kidney and part of the bladder.
  • * The final diagnosis was a bladder glomus tumor, and the patient remains healthy with no signs of recurrence after 15 months, underscoring the need for urologists to consider glomus tumors in their diagnostic process.
View Article and Find Full Text PDF

Pre-sacral glomangioma: a rare localization of glomus tumors: case report.

Ann Med Surg (Lond)

December 2024

General Surgery Department "B", La Rabta Hospital, The Faculty of Medicine, The University of Tunis El Manar, Tunis, Tunisia.

Introduction And Importance: Deep-located glomangiomas are rarely reported. Because of their scarcity, treatment strategy is hard to establish. Herein, the authors report the first case to our knowledge of pre-sacral glomangioma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!